1
Clinical Trials associated with COVID-19 Vaccine, Inactivated, Omicron Strain(Sinovac Biotech)A Phase IIb, Randomized, Open-labeled Trial to Evaluate the Immunogenicity and Safety of One or Two Doses of Booster Vaccine With the COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain in Adults in Hong Kong
This is a randomized, open-labeled, Phase IIb clinical trial.The purpose of this study is to evaluate the immunogenicity and safety of the booster vaccine of using one or two doses of COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain in Adults above 18 Years Old Who Have Completed Two or Three Doses of mRNA Vaccine or CoronaVac®.
100 Clinical Results associated with COVID-19 Vaccine, Inactivated, Omicron Strain(Sinovac Biotech)
100 Translational Medicine associated with COVID-19 Vaccine, Inactivated, Omicron Strain(Sinovac Biotech)
100 Patents (Medical) associated with COVID-19 Vaccine, Inactivated, Omicron Strain(Sinovac Biotech)
100 Deals associated with COVID-19 Vaccine, Inactivated, Omicron Strain(Sinovac Biotech)